Finance

Beta
Lists
Z1TS34:BVMF
Zoetis Inc Bdr
R$ २४.६०
-१.८०%
(-०.४५) 1D
जुन १७, १६:४७:२९ GMT-३  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for Z1TS34...
Open
R$ २५.०५
High
R$ २५.२५
Low
R$ २४.६०
Mkt. cap
३२.३९ अरब
Avg. vol.
४.५९ हजार
Volume
९०८.००
52-wk high
R$ ५५.३१
52-wk low
R$ २३.००
Shares outstanding
४१.९२ करोड
No. of employees
१४ हजार
Open
R$ २५.०५
High
R$ २५.२५
Low
R$ २४.६०
Mkt. cap
३२.३९ अरब
Avg. vol.
४.५९ हजार
Volume
९०८.००
52-wk high
R$ ५५.३१
52-wk low
R$ २३.००
Shares outstanding
४१.९२ करोड
No. of employees
१४ हजार
News stories
From sources across the web
Yahoo Finance
Yahoo Finance
·
५ घण्टा पहिले
What Makes Zoetis (ZTS) an Attractive Bet?
MarketBeat
MarketBeat
·
११ घण्टा पहिले
Fundsmith Investment Services LTD. Buys 30,691 Shares of Zoetis Inc. $ZTS
TradingView
TradingView
·
१५ घण्टा पहिले
Zoetis Inc. Stock 12‑Month Price Target Cut to $119.38, Implies 50% Upside
Profile
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
About Zoetis Inc Bdr
CEOKristin C. Peck
Employees१४.५ हजार
Founded१९५२
HeadquartersParsippany-Troy Hills, न्यु जर्सी, संयुक्त राज्य अमेरिका
Sector-
Websitezoetis.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
२.४६ अरब
२.४० अरब
२.३९ अरब
२.२६ अरब
Cost of goods sold
६४.७० करोड
६८.२० करोड
७१.१० करोड
६४.०० करोड
Cost of revenue
६४.७० करोड
६८.२० करोड
७१.१० करोड
६४.०० करोड
Research and development expenses
१७.२० करोड
१७.०० करोड
१९.९० करोड
१८.०० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६०.८० करोड
५७.२० करोड
६१.८० करोड
५८.४० करोड
Operating expense
८१.३० करोड
७७.४० करोड
८४.८० करोड
७९.५० करोड
Total operating expenses
१.४६ अरब
१.४६ अरब
१.५६ अरब
१.४४ अरब
Operating income
१.०० अरब
९४.४० करोड
८२.८० करोड
८२.७० करोड
Other non operating income
-१०.०० लाख
-
-६०.०० लाख
-१०.०० लाख
EBT including unusual items
९०.२० करोड
८८.७० करोड
७६.१० करोड
७५.८० करोड
EBT excluding unusual items
९५.१० करोड
८९.९० करोड
७८.०० करोड
७७.९० करोड
Income tax expense
१८.४० करोड
१६.६० करोड
१५.८० करोड
१५.७० करोड
Effective tax rate
२०.४०%
१८.७१%
२०.७६%
२०.७१%
Other operating expenses
-
-
-
-
Net income
७१.८० करोड
७२.१० करोड
६०.३० करोड
६०.१० करोड
Net profit margin
२९.१९%
३०.०४%
२५.२६%
२६.५७%
Earnings per share
१.७६
१.७०
१.४८
१.५३
Interest and investment income
१.९० करोड
२.६० करोड
२.५० करोड
२.१० करोड
Interest expense
-५.३० करोड
-५.८० करोड
-५.७० करोड
-६.२० करोड
Net interest expenses
-३.४० करोड
-३.२० करोड
-३.२० करोड
-४.१० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१.१२ अरब
१.०७ अरब
९०.३० करोड
९४.६० करोड
Gain or loss from assets sale
३०.०० लाख
-
-
-६०.०० लाख
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more